ECTRIMS eLearning

RIsk of multiple sclerosis after optic neuritis in patients with normal baseline MRI
Author(s):
H.D. Hambardzumyan
,
H.D. Hambardzumyan
Affiliations:
H.M. Manvelyan
H.M. Manvelyan
Affiliations:
ECTRIMS Learn. Hambardzumyan H. 09/15/16; 146219; P379
Hasmik Hambardzumyan
Hasmik Hambardzumyan
Contributions
Abstract

Abstract: P379

Type: Poster

Abstract Category: Clinical aspects of MS - Neuro-ophthalmology

Introduction: Optic Neuritis (ON) is the initial presentation of multiple sclerosis (MS) in approximately 20% of patients. Although abnormal baseline brain MRI is the strongest conversion predictor, patients with normal MRI can also develop MS. In these patients predictors of conversion are still to be determined. Our objective is to estimate MS risk and identify conversion predictors in ON patients with normal baseline MRI.

Methods: Retrospective chart review of patients with idiopathic ON and normal MRI, presenting to our hospital between 2005 and 2015. Demographic, clinical, paraclinical and treatment data were collected and analyzed.

Results: 44 patients were included. 10 patients converted to MS, seven during the first 2 years and the remaining during the next 3 years. 5-year MS conversion rate was 25.8%. A statistically significant increase in MS conversion rate was associated with retrobulbar ON (p=0.024), a history of previous symptoms suggestive of demyelination (p=0.002), positive oligoclonal bands in CSF (p=0.004) and incomplete recovery (p=0.002). Age, sex, ON laterality, other neurological exam abnormalities, abnormal visual evoked potentials, corticosteroid treatment or ON recurrence were not associated with a significant increase in MS conversion rates.

Conclusion: A considerable proportion of patients with ON and normal baseline brain MRI will develop MS. The risk of conversion appears to be higher during the first 2 years, so follow up, at least during this period, is advisable. Early immunomodulatory treatment may be considered individually, especially in patients with multiple factors associated with increased MS conversion risk

Disclosure: nothing to disclose

Abstract: P379

Type: Poster

Abstract Category: Clinical aspects of MS - Neuro-ophthalmology

Introduction: Optic Neuritis (ON) is the initial presentation of multiple sclerosis (MS) in approximately 20% of patients. Although abnormal baseline brain MRI is the strongest conversion predictor, patients with normal MRI can also develop MS. In these patients predictors of conversion are still to be determined. Our objective is to estimate MS risk and identify conversion predictors in ON patients with normal baseline MRI.

Methods: Retrospective chart review of patients with idiopathic ON and normal MRI, presenting to our hospital between 2005 and 2015. Demographic, clinical, paraclinical and treatment data were collected and analyzed.

Results: 44 patients were included. 10 patients converted to MS, seven during the first 2 years and the remaining during the next 3 years. 5-year MS conversion rate was 25.8%. A statistically significant increase in MS conversion rate was associated with retrobulbar ON (p=0.024), a history of previous symptoms suggestive of demyelination (p=0.002), positive oligoclonal bands in CSF (p=0.004) and incomplete recovery (p=0.002). Age, sex, ON laterality, other neurological exam abnormalities, abnormal visual evoked potentials, corticosteroid treatment or ON recurrence were not associated with a significant increase in MS conversion rates.

Conclusion: A considerable proportion of patients with ON and normal baseline brain MRI will develop MS. The risk of conversion appears to be higher during the first 2 years, so follow up, at least during this period, is advisable. Early immunomodulatory treatment may be considered individually, especially in patients with multiple factors associated with increased MS conversion risk

Disclosure: nothing to disclose

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies